Further, other studies signified that MSCs-derived exosomes could reduce the IBD severity in animal models by up-regulation of IL-10 while attenuating TNF-α, IL-1β, IL-6, iNOS, and, more importantly, IL-7 levels in colon tissues and spleens of treated animals [180–182]. The gene discussed is IL1B; the disease is inflammatory bowel disease.